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Introduction
Diabetes is the most frequent endocrine disease in de-
veloped countries and one of the most common non-com-
municable diseases (NCDs) globally, estimated to have 
affected 463 million people in 2019 and projected to affect 
578 million by 2030 and 700 million by 20451. It is among 
the top ten causes of death in adults and was estimated to 
have caused 4,2 million deaths globally in 20191. Besides 
the high rate of premature mortality and lower quality of 
life, diabetes and its long-term complications also impose 
a significant economic impact on countries, health sys-
tems, and individuals with diabetes and their families. In 
2019, global health expenditure on diabetes had been USD 
760 billion, and International Diabetes Federation (IDF) 
projects that total diabetes-related health expenditure 
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A B S T R A C T
Diabetic retinopathy (DR) is the leading cause of preventable blindness in working-age adults associated with devas-
tating personal and socioeconomic consequences. The increasing use of anti-vascular endothelial growth factor (anti-
VEGF) agents over the past decade and telemedicine implementation in systematic DR screening resulted in a declining 
trend of new blindness due to diabetes in several countries. Telemedicine is the remote delivery of healthcare services over 
the telecommunications infrastructure. It allows healthcare providers to evaluate, diagnose, and treat patients without 
the need for an in-person visit. Teleophthalmology is a telemedicine branch, mostly focused on diabetic retinopathy and 
retinopathy of prematurity. Screening for DR in Croatia is commonly performed annually, only by ophthalmologists using 
dilated slit-lamp biomicroscopic fundus examination. Due to the insufficient number of ophthalmologists and the lack of 
a formal call system, many diabetic patients do not perform annual screening. In an ideal DR screening model in Croatia, 
each diabetes center in university or general hospitals throughout Croatia (17 centers) would have one small digital fun-
dus camera and an educated nurse who would perform dilated fundus photography. Electronic images from diabetes 
centers would be transferred for remote grading to the same hospitals’ ophthalmology departments or a central grading 
center for DR screening in Croatia. Grading for DR would be performed by an ophthalmologist, medical retina specialist. 
Patients would be annually invited by mail from the National Diabetes Registry to come to the nearest diabetes center for 
a fundus photographing and DR screening. Each patient with a positive result would be promptly referred to the medical 
retina specialist at the closest ophthalmology department for further examination and treatment.
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will reach 825 billion by 2030 and USD 845 billion by 
20451. 
Diabetic retinopathy (DR) is a long-term microvascular 
complication of diabetes and the leading cause of blindness 
in working-age adults associated with devastating per-
sonal and socioeconomic consequences2. According to the 
META-EYE Study, more than one-third of people with 
diabetes worldwide have DR, and 10.2% have vision-
threatening DR (VTDR), including proliferative DR (PDR) 
and diabetic macular edema (DME)3. Vision loss due to 
diabetes can be prevented if retinopathy is early diag-
nosed in its painless and asymptomatic stages and ap-
propriately and timely treated. The WHO Universal Eye 
Health: A Global Action Plan 2014–2019 outlined the need 
to reduce the prevalence of preventable blindness, includ-
ing that related to diabetes4. The increasing use of anti-
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vascular endothelial growth factor (anti-VEGF) agents 
over the past decade and telemedicine implementation in 
systematic DR screening resulted in a declining trend of 
new visual impairment and blindness due to diabetes in 
several countries5,6. Thus, establishing successful DR 
screening programs worldwide is an essential task that 
would benefit from both sociopolitical acceptance and 
health care professional commitment on a long-term basis.
What Is Telemedicine?
There are many definitions of telemedicine, but in most 
cases, all definitions say that telemedicine is managing 
patients from a distance. That is true, but as telemedicine 
is not a medical specialization per se, we cannot say that 
telemedicine is just managing patients in a remote area 
or from a distance, which is, in fact, its essential purpose. 
However, as we know, the basic technics of patient ex-
amination in medicine are observation, auscultation, and 
percussion and to perform that from a distance is merely 
impossible and to make telemedicine possible, the im-
provement in telecommunication, computers, and also in 
medicine was necessary to allow us today to speak about 
telemedicine. Thus, telemedicine is the integration and 
implementation of modern technology in telecommunica-
tion, computers, and medicine, and without any part of 
this chain, telemedicine would be impossible7.
Telemedicine began with the invention of the telephone 
in the 19th century when doctors started to manage and 
advise their patients by the phone. Further improvement 
in telemedicine development happened on 14th February 
1946 with the first electronic computer named ENIAC. 
Some advances in medicine were also needed to implement 
telemedicine principles significantly. As the picture 
speaks more than a thousand words, visualization of inner 
body structures was a big step forward done by W. Rönt-
gen in 1895. In that same year, W. Einthoven made an-
other big step forward with ECG diagnostics. Also, from 
that time till these days, significant improvements were 
made in biochemistry and laboratory diagnostics. All 
these small but significant parts of the telemedicine chain 
were necessary to make it possible.
Here one could probably say that we forgot something, 
and yes, we did not speak about the Internet yet. We may 
consider the Internet as a breakthrough in telecommuni-
cations. In short, we may say that the Internet, the com-
puter network of all networks, as we know it today, has its 
roots in the ARPANET project from 1969 when it was 
constructed, computer networks were able to survive a 
nuclear attack. 
Over the years, every part of the telemedicine chain 
improved more and more. Telecommunications became 
much faster, and computer graphics became much more 
precise and realistic. Computer graphics improvements 
were so high that the human eye could not register sev-
eral colors that can be seen even on a standard home com-
puter, and improved diagnostic technology makes the 
circle of telemedicine finally completed. 
As said before, telemedicine is not a separate special-
ization in medicine. However, telemedicine principles are 
applied in different branches of modern medicine, so today 
we speak about teleophthalmology, teleradiology, telecar-
diology, telepathology, etc.
We also can divide telemedicine into synchronous and 
asynchronous parts8.  Synchronous or “online” is the kind 
of telemedicine when the giver and receiver of the tele-
medicine care are on the different side of the telemedicine 
bridge simultaneously, and the medical care is given in 
real-time. We are talking about asynchronous telemedi-
cine when some amount of time shift is present. We cannot 
forget that practicing medicine means permanent educa-
tion, so telemedicine principles are beneficial in perma-
nent education.
Moreover, finally, we cannot forget the General Data 
Protection Regulation (GDPR). Like Apollo, the physician, 
swears us all, and Asclepius, Hygieia, Panacea, and all the 
gods and goddesses as our witnesses, we must keep our 
patient’s data confidential. The Internet is nowadays ev-
erything, but it is not a safe place, and we must have that 
on our minds. So, we must obtain the security of a patient’s 
data during telemedicine implementation in patients man-
agement. Let us say that we have Alice and Bob, and they 
are on each side of the telemedicine bridge, and Eve is an 
“intruder” and wants to see what Alice and Bob are doing. 
The security of network communication between Alice and 
Bob is based on the three most important characteristics: 
confidentiality, integrity, and availability (Figure 1)9. The 
abbreviation “CIA” describes these security conditions of 
data transfer over the network. Confidentiality is obtained 
by encryption, which can be symmetric or asymmetric. 
Symmetric encryption means that Alice and Bob have the 
same private keys, while in asymmetric encryption, both 
sides, Alice and Bob, must have their own personal and 
public key. Encryption disables the third person, in this 
case, Eve, to access our patient’s original data. The data 
integrity secures Alice and Bob that the data would not be 
changed during network transfer, and that data is the 
same as the original. Hashing is the name of the algorithm 
or a method that enables data integrity. Data that must be 
transferred over the network pass through the Hash func-
tion, and then we get a unique data code on which another 
side, in this case, Bob, may check by entering of decrypted 
data in the Hash function. One of the most common Hash 
functions today is SHA256. This function generates a 256-
bit code no matter how big the original data are. Avail-
ability is obtained by the possibility of communication at 
every moment. That is made possible by redundant com-
munication canal or by the redundant communication sys-
tem. In short, that would be about the security of network 
communication and the security of data in transit. Similar 
principles of confidentiality, integrity, and availability ob-
tain the protection of data on a data basis.
Telemedicine for Ophthalmology
Telemedicine for ophthalmology or teleophthalmology 
is a telemedicine branch that delivers eye care through 
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Screening for Diabetic Retinopathy
Screening for DR is an essential cost-effective part of 
diabetes management13,14. However, even if enough oph-
thalmologists are available, using ophthalmologists to 
screen every person with diabetes usually is not feasible 
and is likely to be an inefficient use of resources. Theo-
retically, a screening examination could include a com-
plete ophthalmic examination with best-corrected visual 
acuity after refraction, pupil dilation, slit-lamp biomicro-
scopic fundus examination, and the latest retinal imaging, 
such as with wide-field retinal photography and optical 
coherence tomography (OCT). However, such screening 
examinations are not performed routinely, even in high-
income countries. 
The current guidelines suggest the minimum screen-
ing examination components should include a screening 
vision examination (before pupil dilation) and a retinal 
examination adequate for DR classification15. Nowadays, 
low-cost fundus cameras are widely available, and fundus 
photography telemedicine has become a good option for 
obtaining the retinal examination16. This method involves 
an educated nurse or trained photographer taking retinal 
images and sending them to a remote trained reader (typ-
ically an ophthalmologist) for interpretation. Fundus pho-
tography telemedicine has been shown to have acceptable 
sensitivity and specificity for DR screening compared to 
in-person screens17. It is also cost-effective and generally 
well-liked by patients18. Although fundus photography 
telemedicine increases screening rates and its implemen-
tation in systematic DR screening resulted in a declining 
trend of new visual impairment and blindness due to dia-
betes in several countries5,6, still there are logistical bar-
riers, lack of educated professionals, cost issues, and time 
delays. Such limitations created interest in assessing im-
ages using fully automated artificial intelligence (AI)-
based grading systems19. In real-time, the system decides 
whether a patient requires a referral, and it is much 
cheaper than having ophthalmologists conduct screening. 
In April 2018, the US Food and Drug Administration 
(FDA) approved an AI algorithm, developed by IDx, used 
digital medical equipment and telecommunications tech-
nology. Today, teleophthalmology applications include ac-
cess to the ophthalmologist for patients in remote areas, 
ophthalmic disease screening, diagnosis and monitoring, 
and distant learning10. Teleophthalmology enables health 
professionals to take ocular images and allow the ophthal-
mologist, health care professionals, and researchers on the 
other side to carry out the abovementioned requests. The 
required equipment includes a camera that can take ocu-
lar images and a computer terminal with network capa-
bilities that transfers the images. Current teleophthalmol-
ogy is mostly focused on the two areas, DR and retinopathy 
of prematurity (ROP). Successful use of telemedicine in 
these areas has provided benefits to patients, health care 
systems, and society. Although effective treatments for 
high-risk DR have existed for more than four decades, DR 
remains the leading cause of new blindness among work-
ing-age adults. A significant contributor to that is the pa-
tients’ inability to access regular fundus examinations. 
Telemedicine programs can improve patient access to 
the annual DR screening through patient imaging in a 
primary care setting or diabetes care center11. Given the 
high proportion of currently unable patients possibility to 
obtain a fundus examination at the proper frequency, ex-
pansion of telemedicine for ophthalmology programs would 
likely result in the earlier provision of care for eyes with 
DR. Telemedicine for ROP has a proven ability to improve 
access to eye care for premature infants at high risk for 
ROP12. Timely diagnosis and treatment of ROP are essen-
tial for successful outcomes, especially in remote areas. 
These two clinical areas demonstrate that telemedicine 
can successfully improve and extend ophthalmic care us-
ing imaging technology. Other telemedicine areas within 
ophthalmology, such as intraocular pressure monitoring, 
optic nerve analysis, macular disease monitoring, visual 
field analysis, and anterior segment diagnosis, are also 
being established. Also, the capacity to perform remotely, 
face-to-face exams, and consults in routine and emergent 
clinical situations is advancing with improved two-way 
communication technologies.
Fig. 1. The principles of telemedicine today.
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with Topcon Fundus camera (Topcon Medical) for DR 
identification20. The device, called IDx-DR, is a software 
program that uses an AI algorithm to analyze images of 
the eye taken with a retinal camera Topcon NW400. The 
digital images of a patient’s retinas are uploaded to a cloud 
server on which IDx-DR software is installed. If the im-
ages are of sufficient quality, the software provides one of 
two results: (1) “more than mild diabetic retinopathy de-
tected: refer to an eye care professional” or (2) “negative 
for more than mild diabetic retinopathy: rescreen in 12 
months”. If a positive result is detected, patients should 
see an eye care provider for further diagnostic evaluation 
and necessary treatment as soon as possible.
Regardless of the screening method, the most impor-
tant is that the DR screening service must be well con-
nected with the proper ophthalmology department in 
which all further diagnostic procedures and treatments 
(laser, intravitreal injections, vitrectomy) if needed, will 
be performed21,22. The guidelines suggest that patients 
with positive results will not benefit from the DR screen-
ing program without adequate and timely access to oph-
thalmic care15. Therefore, DR screening should only be 
initiated after sufficient access for facilities with access to 
minimal treatment, including a laser machine’s availabil-
ity within three months of screening.
Current Status of Screening for Diabetic  
Retinopathy in Croatia
The Republic of Croatia is a country located in Central 
and Southeast Europe on the Adriatic Sea coast. It has an 
area of 56,594 square kilometers and a population of 
4,067,500. According to the Croatian National Diabetes 
Registry, 315,298 of Croatian adults (7.8% of the popula-
tion) had diabetes in 201923. Besides the high prevalence 
of diabetes, an additional burden is that almost 40% of 
patients have not been diagnosed with diabetes, so the 
total number of diabetic patients in Croatia is estimated 
to be 500,00023. The official prevalence of DR and blind-
ness due to diabetes in Croatia is unfortunately unknown 
because the registry of diabetic eye disease and blindness 
due to diabetes is insufficient and not regularly updated.
In Croatia, there are no national recommendations or 
clinical guidelines on diabetic retinopathy screening and 
treatment. Screening for DR is commonly performed annu-
ally24, using dilated slit-lamp biomicroscopic fundus ex-
amination only by ophthalmologists, mostly medical retina 
specialists. Sometimes longer intervals between screening 
(e.g., 1.5 or 2 years) are recommended, particularly for 
older patients with type 2 diabetes, previously no signs of 
diabetic retinopathy, and good metabolic control. Neither 
nurses, technicians, nor optometrists are included in the 
fundus photographing or screening. There are about 400 
active ophthalmologists in Croatia, among them 45 medical 
retina specialists trained to screen and treat DR and DME. 
No new technologies such as automated grading, electron-
ic data transfer systems (including telemedicine), artificial 
intelligence are introduced into the DR screening in Croa-
tia. OCT is used only for diagnosing and monitoring of 
DME. There is neither a formal call-recall system nor 
people with diabetes are invited for screening from the 
diabetes register, GP register, or dispensing records. They 
attend for fundus examination by verbal recommendation 
of a diabetologist or GP or by their own request. There is 
also no national survey or system to monitor the screening 
frequency or if people attend for fundus examination.
In Croatia, PDR and DME are treated according to the 
Diabetic Retinopathy Guidelines by the Royal College of 
Ophthalmologists, London, UK25, and Guidelines for the 
Management of Diabetic Macular Edema by the European 
Society of Retina Specialists (EURETINA)26. Laser pho-
tocoagulation, intravitreal injection (anti-VEGF, steroids), 
and vitrectomy are available for patients with PDR and 
DME in ophthalmology departments in all university hos-
pitals, several general hospitals, and private practices. 
However, unfortunately, due to many diabetic patients 
and the insufficient number and time of medical retina 
specialists and VR surgeons, the situation is serious with 
a too long period, about six to eight months, from PDR and 
DME diagnosis to the start of their treatment.
Ideal Model for Screening for Diabetic 
Retinopathy in Croatia
In an ideal DR screening model in Croatia, each diabe-
tes center in university or general hospitals throughout 
Croatia (17 centers) would have one small digital fundus 
camera and an educated nurse or technician who would 
perform dilated fundus photography. Electronic images 
from screening diabetes centers would be transferred (elec-
tronic data transfer) for remote grading (telemedicine) to 
the same hospitals’ ophthalmology departments where the 
diabetes centers are located. Grading would be performed 
by an ophthalmologist, medical retina specialist working 
there. In parts of Croatia, where there are no ophthal-
mologists, the images would be transferred for grading to 
a central grading center for DR screening in Croatia that 
is less expensive than relocating ophthalmologists. Pa-
tients would be annually invited by mail from the Nation-
al Diabetes Registry to come to the nearest diabetes center 
for a fundus photographing and DR screening. Each pa-
tient with a positive result would be promptly referred to 
the ophthalmologist, medical retina specialist at the near-
est ophthalmology department for further examination 
and treatment. During the screening, the educated nurse 
would conduct continuous education of patients on the im-
portance of regular DR screening and good control of well-
known risk factors: glycemia, arterial hypertension, and 
dyslipidemia to prevent vision loss due to diabetes. Sig-
nificant, but not unbearable, barriers to implementing this 
ideal screening model in Croatia are lack of equipment 
(digital fundus cameras) and deficiency of educated nurses 
and technicians for fundus photographing. Also, there are 
no electronic data transfer systems (including telemedi-
cine) in ophthalmology in Croatia. Still, such systems are 
used routinely in radiology, so it should not be a problem 
to implement them in ophthalmology.
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TELEMEDICINA U PROBIRU DIJABETIČKE RETINOPATIJE U HRVATSKOJ: SAN KOJI BI MOGAO 
POSTATI STVARNOST
S A Ž E T A K
Dijabetička retinopatija (DR) vodeći je uzrok preventabilne sljepoće radno-aktivnih osoba povezan s razornim osobnim 
i socioekonomskim posljedicama. Sve veća primjena anti-VEGF lijekova u zadnjem desetljeću i uvođenje telemedicine u 
sustavni probir DR-a rezultirali su smanjenjem novonastale sljepoće zbog dijabetesa u nekim državama. Telemedicina 
je pružanje zdravstvenih usluga na daljinu putem telekomunikacijske infrastrukture. Pružateljima zdravstvenih uslu-
ga time je omogućeno postavljenje dijagnoze i liječenje bolesnika bez potrebe za osobnom posjetom. Teleoftalmologija je 
grana telemedicine uglavnom usmjerena na dijabetičku retinopatiju i retinopatiju nedonoščadi. Probir DR-a u Hrvatskoj 
provode samo oftalmolozi, obično jednom godišnje, pregledom očne pozadine nekontaktnim lećama na biomikroskopu. 
Zbog nedovoljnog broja oftalmologa i nepostojanja formalnog sustava poziva, mnogi bolesnici sa šećernom bolešću ne 
provode godišnje očne preglede. U idealnom modelu probira DR-a u Hrvatskoj, svaki centar za dijabetes u sveučilišnim 
ili općim bolnicama diljem Hrvatske (17 centara) imao bi jednu malu digitalnu fundus kameru i educiranu medicinsku 
sestru koja bi izvodila slikanje očne pozadine u midrijazi. Slike iz centara za dijabetes elektronski bi se prenosile na 
očitavanje u oftalmološke odjele istih bolnica ili u središnji centar očitavanja i probira DR u Hrvatskoj. Očitavanje slika 
i stupnjevanje DR-a izvodio bi oftalmolog, subspecijalist za stražnji segment oka. Bolesnici bi jednom godišnje poštom 
bili pozivali iz Nacionalnog registra za dijabetes da dođu u najbliži centar za dijabetes radi probira DR-a slikanjem očne 
pozadine. Svaki bolesnik s pozitivnim nalazom bio bi odmah upućen subspecijalistu za stražnji segment oka najbližeg 
oftalmološkog odjela na daljnju dijagnostičku obradu i liječenje.
